Literature DB >> 6206993

[Cholestasis after antiarrhythmic therapy with propafenone].

K H Konz, P A Berg, L Seipel.   

Abstract

Propafenone, three times 150 mg/d over 33 days and two years later at the same dosage over six days, was administered to an 84-year-old man with ventricular extrasystoles (Lown IVa). Both times intrahepatic biliary stasis occurred, presumably a sign of a drug-allergic hepatitis. All other possible causes in the differential diagnosis were excluded. The lymphocyte transformation test demonstrated in vitro propafenone-sensitive patient-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206993     DOI: 10.1055/s-2008-1069406

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

2.  Propafenone hepatotoxicity: report of two new cases.

Authors:  Daniel Cocozzella; José Curciarello; Osvaldo Corallini; Adriana Olivera; María Malca Alburquerque; Emilio Fraquelli; Liliana Zamagna; Alejandro Olenchuck; Alberto Cremona
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 3.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 4.  Propafenone hepatotoxicity: report of a new case and review of the literature.

Authors:  Lara B Younan; Kassem A Barada; Walid G Faraj; Ayman N Tawil; Mark N Jabbour; Maurice Y Khoury; Nadim Mw El-Majzoub; Mohamad A Eloubeidi
Journal:  Saudi J Gastroenterol       Date:  2013 Sep-Oct       Impact factor: 2.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.